Abstract
Today it is common to conduct research in collaboration with colleagues from different disciplines and institutions. The INterdisciplinary HEalth Research International Team on BReast CAncer susceptibility (INHERIT BRCAs), involves Canadian and international experts from diverse fields working with health service providers, patients and collaborators from the World Health Organization and other European networks. Evidence-based information and knowledge transfer drive our efforts to advance genomic research to understand the genetic basis of cancer susceptibility and treatment response. Several goals reveal the interdisciplinary team approach: (a) to estimate the prevalence and penetrance of BRCA1 and BRCA2 mutations and their deleterious impact upon different populations; (b) to pinpoint novel breast cancer susceptibility loci; (c) to assess the efficacy of clinical interventions; (d) to address changes in quality of life and health-related behaviour from the decision to undergo genetics testing and during follow-up; (e) to evaluate legal, social and ethical implications; and, finally; (f) to promote professional and public education by facilitating the transfer of research findings to clinical practice and informing policy makers. The lessons learned by the INHERIT research team and future challenges are presented.
Similar content being viewed by others
References
D Ford DF Easton M Stratton et al. (1998) ArticleTitleGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 IssueID3 676–89 Occurrence Handle10.1086/301749 Occurrence Handle1:CAS:528:DyaK1MXlvFeh Occurrence Handle9497246
InstitutionalAuthorNameDepartment of Health (2003) Genetics White Paper: Our Inheritance, Our Future – Realising the Potential of Genetics in the National Health System Department of Health London, UK
MJ Khoury W Burke EJ Thomson (2000) Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease Oxford University Press Oxford
MJ Khoury J Little W Burke (2004) Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease Oxford University Press Oxford
SM Lippman B Levin DE Brenner et al. (2004) ArticleTitleCancer prevention and the American Society of Clinical Oncology J Clin Oncol 22 IssueID19 3848–51 Occurrence Handle10.1200/JCO.2004.07.139 Occurrence Handle15353541
AE Guttmacher FS Collins RH Carmona (2004) ArticleTitleThe family history – more important than ever N Engl J Med 351 IssueID22 2333–6 Occurrence Handle10.1056/NEJMsb042979 Occurrence Handle1:CAS:528:DC%2BD2cXhtValtrrM Occurrence Handle15564550
K Hemminki C Eng (2004) ArticleTitleClinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans J Med Genet 41 IssueID11 801–7 Occurrence Handle10.1136/jmg.2004.022731 Occurrence Handle1:STN:280:DC%2BD2crkvVaisg%3D%3D Occurrence Handle15520403
KL Nathanson R Wooster BL Weber (2001) ArticleTitleBreast cancer genetics: What we know and what we need Nat Med 7 IssueID5 552–6 Occurrence Handle10.1038/87876 Occurrence Handle1:CAS:528:DC%2BD3MXjsVakurs%3D Occurrence Handle11329055
BA Ponder (2001) ArticleTitleCancer genetics Nature 411 IssueID6835 336–41 Occurrence Handle10.1038/35077207 Occurrence Handle1:CAS:528:DC%2BD3MXktVSjsr4%3D Occurrence Handle11357140
AR Horwitz (2003) ArticleTitleBuilding bridges through collaboration – a pathway for interdisciplinary research Trends Cell Biol 13 IssueID1 2–3 Occurrence Handle10.1016/S0962-8924(02)00003-X Occurrence Handle12480333
GC O’Connor MP Rice L Peters JG Veryzer (2003) ArticleTitleManaging interdisciplinary, longitudinal research teams: Extending grounded theory-building methodologies Org Sci 14 IssueID4 353–73
JT Klein (1990) Interdisciplinarity: History, Theory and Practice Wayne State University Press Detroit, MI
J Qin FW Lancaster B Allen (1997) ArticleTitleTypes and levels of collaboration in interdisciplinary research in the sciences Journal of the American Society for Information Science 48 IssueID10 893–916 Occurrence Handle10.1002/(SICI)1097-4571(199710)48:10<893::AID-ASI5>3.0.CO;2-X
N Metzger RN Zare (1999) ArticleTitleInterdisciplinary research: From belief to reality Science 283 IssueID5402 642–3 Occurrence Handle10.1126/science.283.5402.642 Occurrence Handle1:CAS:528:DyaK1MXot1Kjug%3D%3D
JS Altshuler D Altshuler (2004) ArticleTitleOrganizational challenges in clinical genomic research Nature 429 IssueID6990 478–81 Occurrence Handle10.1038/nature02629 Occurrence Handle1:CAS:528:DC%2BD2cXkt1Onsbk%3D Occurrence Handle15164075
J Lomas (2000) ArticleTitleConnecting research and policy Can J Policy Res 1 140–4
C Lenfant (2003) ArticleTitleShattuck lecture – clinical research to clinical practice – lost in translation? N Engl J Med 349 IssueID9 868–74 Occurrence Handle10.1056/NEJMsa035507 Occurrence Handle12944573
A Forbes P Griffiths (2002) ArticleTitleMethodological strategies for the identification and synthesis of ‘evidence’ to support decision-making in relation to complex healthcare systems and practices Nurs Inq 9 IssueID3 141–55 Occurrence Handle10.1046/j.1440-1800.2002.00146.x Occurrence Handle12199878
B Vogelstein KW Kinzler (2004) ArticleTitleCancer genes and the pathways they control Nat Med 10 IssueID8 789–99 Occurrence Handle10.1038/nm1087 Occurrence Handle1:CAS:528:DC%2BD2cXmtFWrt7o%3D Occurrence Handle15286780
PD Pharoah A Antoniou M Bobrow et al. (2002) ArticleTitlePolygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 IssueID1 33–6 Occurrence Handle10.1038/ng853 Occurrence Handle1:CAS:528:DC%2BD38Xjt1Kgu7g%3D Occurrence Handle11984562
PD Pharoah AM Dunning BA Ponder DF Easton (2004) ArticleTitleAssociation studies for finding cancer-susceptibility genetic variants Nat Rev Cancer 4 IssueID11 850–60 Occurrence Handle10.1038/nrc1476 Occurrence Handle1:CAS:528:DC%2BD2cXptFegt74%3D Occurrence Handle15516958
SA Narod (2002) ArticleTitleModifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2 IssueID2 113–23 Occurrence Handle10.1038/nrc726 Occurrence Handle12635174
H Jernstrom J Lubinski HT Lynch et al. (2004) ArticleTitleBreast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 96 IssueID14 1094–8 Occurrence Handle1:STN:280:DC%2BD2czmt1Kktg%3D%3D Occurrence Handle15265971
AC Antoniou DF Easton (2003) ArticleTitlePolygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 IssueID3 190–202 Occurrence Handle10.1002/gepi.10261 Occurrence Handle14557987
Smith P, Spurdle A, Harrington PA et al. Analysis of polymorphisms in DNA repair genes as modifiers of breast cancer risk in BRCA1 and BRCA2 carriers. The American Society of Human Genetics, 54th Annual Meeting, October 26–30, 2004, Toronto, Ontario, Canada. Abstract #438, p. 100.
Simard J, Dumont M, Moisan A-M et al. Molecular epidemiology of BRCA1 and BRCA2 mutations in French Canadian breast/ovarian families. The American Society of Human Genetics, 54th Annual Meeting, October 26–30, 2004, Toronto, Ontario, Canada. Abstract #480, p. 107.
D Goldgar D Easton A Deffenbaugh et al. (2004) ArticleTitleIntegrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2 Am J Hum Genet 75 535–44 Occurrence Handle10.1086/424388 Occurrence Handle1:CAS:528:DC%2BD2cXnvFaktLg%3D Occurrence Handle15290653
OM Serova S Mazoyer N Puget et al. (1997) ArticleTitleMutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Am J Hum Genet 60 IssueID3 486–95 Occurrence Handle1:CAS:528:DyaK2sXhvFGjtLk%3D Occurrence Handle9042907
AC Antoniou DF Easton (2003) ArticleTitlePolygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 IssueID3 190–202 Occurrence Handle10.1002/gepi.10261 Occurrence Handle14557987
D Thompson JS Witte M Slattery D Goldgar (2004) ArticleTitleIncreased power for case–control studies of single nucleotide polymorphisms through incorporation of family history and genetic constraints Genet Epidemiol 27 IssueID3 215–24 Occurrence Handle10.1002/gepi.20018 Occurrence Handle15389928
CR Scriver (2001) ArticleTitleHuman genetics: Lessons from Quebec populations Annu Rev Genom Hum Genet 2 69–101 Occurrence Handle1:CAS:528:DC%2BD3MXos1antLk%3D
H Vézina F Durocher M Dumont L Houde et al. (2005) ArticleTitleMolecular and Genealogical Characterization of the R1443X-BRCA1 Mutation in High-risk French-Canadian Breast/Ovarian Cancer Families Hum Genet 117 IssueID(2–3) 119–132 Occurrence Handle15883839
E McNally A Cambon-Thomsen (2004) Ethical, Legal and Social Aspects of Genetic Testing: Research, Development and Clinical Applications European Commission Brussels
Z Einbeigi A Bergman P Karlsson et al. (2003) ArticleTitlePopulation study on BRCA1/2 mutations in women with breast and ovarian cancer in western Sweden Breast 12 IssueIDS1 S17
R Inoue T Ushijima T Fukutomi et al. (1997) ArticleTitleBRCA2 germline mutations in Japanese breast cancer families Int J Cancer 74 IssueID2 199–204 Occurrence Handle10.1002/(SICI)1097-0215(19970422)74:2<199::AID-IJC11>3.0.CO;2-9 Occurrence Handle1:CAS:528:DyaK2sXjtleqsb4%3D Occurrence Handle9133456
DM Eccles (2003) ArticleTitleGenetic testing for BRCA1 mutation in the UK Lancet 361 IssueID9352 178–9 Occurrence Handle10.1016/S0140-6736(03)12213-1 Occurrence Handle12531609
W Burke M Daly J Garber et al. (1997) ArticleTitleRecommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium JAMA 277 IssueID12 997–1003 Occurrence Handle10.1001/jama.277.12.997 Occurrence Handle1:STN:280:ByiB38fgtl0%3D Occurrence Handle9091675
Noorani HZ, McGahan L. Predictive Genetic Testing for Breast and Prostate Cancer. Ottawa, Canada: Canadian Coordinating Office for Health and Technology Assessment (CCOHTA) 1999; Report No. 4.
Goldgar D, Bonnardel C, Renard H, Yaqoubi O. The International BRCA1/2 Carrier Cohort Study: Purpose, Rationale and study design. Breast Cancer Res 2000; 2: e010.
A Baum AL Friedman SG Zakowski (1997) ArticleTitleStress and genetic testing for disease risk Health Psychol 16 IssueID1 8–19 Occurrence Handle10.1037/0278-6133.16.1.8 Occurrence Handle1:STN:280:ByiC1c%2FmtlI%3D Occurrence Handle9028812
M Dorval E Maunsell MJ Dugas J Simard (2001) ArticleTitleSupport groups for people carrying a BRCA mutation CMAJ 165 IssueID6 740 Occurrence Handle1:STN:280:DC%2BD3MrjvVaitw%3D%3D Occurrence Handle11584558
Dorval M, Maunsell E, Patenaude AF et al. Elapsed time to disclosure of BRCA1/2 genetic testing result and participants’ distress: Preliminary finding from a research setting. Psycho-Oncology 2000; 9(5 Suppl) abstract #341.
Dorval M, Gauthier G, Maunsell E et al. Are women with an inconclusive BRCA1/2 genetic tests result falsely reassured? Psycho-Oncology 2003; 124(4 Suppl).
M Dorval S Morel E Maunsell et al. (2003) ArticleTitleWhen using the Impact of Events Scale to assess psychological distress in the context of BRCA1/2 testing, does the event matter? Psycho-Oncology 12 IssueID4 Suppl 307
Dorval M, Davilmar A, Rouleau I et al. Men undergoing BRCA1/2 genetic testing: Who are they and why do they do it? Psycho-Oncology 2005; 14(s85).
I Rouleau J Chiquette M Plante et al. (2004) ArticleTitleChanges in health-related behaviours following BRCA 1/2 genetic testing: The case of hormone replacement therapy J Obstet Gynaecol Can 26 IssueID12 1059–66 Occurrence Handle15607041
MH Vallee I Rouleau M Plante et al. (2005) ArticleTitleHormone therapy use among women tested for BRCA1/2 mutations following the publication of the Women’s Health Initiative Study results J Obstet Gynaecol Can 27 IssueID4 321 Occurrence Handle15937602
BJ Wilson K Forrest ER Teijlingen et al. (2004) ArticleTitleFamily communication about genetic risk: The little that is known Genetics 7 15–24
T Lemmens Y Joly BM Knoppers (2004) ArticleTitleGenetics and life insurance: A comparative approach GenEdit 2 IssueID2 1–15
EW Clayton (2004) Policy challenges ethical, legal, and social implications of genetics Magill (Eds) Genetic and Ethics An Interdisciplinary Study Saint Louis University Press Saint Louis 23–34
InstitutionalAuthorNameWorld Health Organization (1997) Statement of WHO Expert Advisory Group on Ethical Issues in Medical Genetics WHO Geneva
BM Knoppers Y Joly (2004) ArticleTitlePhysicians, genetics and life insurance CMAJ 170 IssueID9 1421–3 Occurrence Handle15111477
L Skene (1998) ArticleTitlePatients’ rights or family responsibilities? Two approaches to genetic testing Med Law Rev 6 IssueID1 1–41 Occurrence Handle11657222
M Letendre B Godard (2004) ArticleTitleExpanding the physician’s duty of care: A duty to recontact? Med Law 23 IssueID3 531–9 Occurrence Handle15532946
JL Benkendorf JE Reutenauer CA Hughes et al. (1997) ArticleTitlePatients’ attitudes about autonomy and confidentiality in genetic testing for breast–ovarian cancer susceptibility Am J Med Genet 73 IssueID3 296–303 Occurrence Handle10.1002/(SICI)1096-8628(19971219)73:3<296::AID-AJMG13>3.0.CO;2-E Occurrence Handle1:STN:280:DyaK1c%2Fns1Wksg%3D%3D Occurrence Handle9415688
J Birdsell J Atkinson-Grosjean R Landry (2002) Knowledge Translation in Two New Programs: Achieving the ‘Pasteur Effect’ Canadian Institutes of Health Research Ottawa
C Shaw A McIntosh G Evans et al. (2004) Clinical Guidelines and Evidence Review for the Classification and Care of Women at Risk of Familial Breast Cancer National Collaborating Centre for Primary Care/University of Sheffield London
F Eisinger B Bressac D Castaigne et al. (2004) ArticleTitleIdentification and management of hereditary predisposition to cancer of the breast and the ovary – update 2004 Bull Cancer 91 IssueID3 219–37 Occurrence Handle15171047
JM Grimshaw RE Thomas G MacLennan et al. (2004) ArticleTitleEffectiveness and efficiency of guideline dissemination and implementation strategies Health Technol Assess 8 IssueID6 iii–72 Occurrence Handle1:STN:280:DC%2BD2c%2Fnt1Wntg%3D%3D Occurrence Handle14960256
DR Carlow (2000) ArticleTitleStatus report: Canadian association of provincial cancer agencies Chronic Diseases Canada 21 IssueID1 30–3 Occurrence Handle1:STN:280:DC%2BD3c3nsVamsA%3D%3D
HF Vasen NE Haites DG Evans et al. (1998) ArticleTitleCurrent policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group Eur J Cancer 34 IssueID12 1922–6 Occurrence Handle10.1016/S0959-8049(98)00288-3 Occurrence Handle1:STN:280:DyaK1M7ksleqtQ%3D%3D Occurrence Handle10023316
InstitutionalAuthorNameWorld Health Organization (1997) Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Service. Report of a WHO Meeting on Ethical Issues in Medical Genetics World Health Organization Geneva
World Health Organization. Control of Hereditary Diseases. Geneva: WHO 1996; Report No. 865.
J Emery A Lucassen M Murphy (2001) ArticleTitleCommon hereditary cancers and implications for primary care Lancet 358 IssueID9275 56–63 Occurrence Handle10.1016/S0140-6736(00)05257-0 Occurrence Handle1:STN:280:DC%2BD3Mvgt1Glug%3D%3D Occurrence Handle11454400
InstitutionalAuthorNameThe New York State Task Force on Life and the Law (2000) Integrating Genetic Services into Clinical Care. Genetic Testing and Screening in the Age of Genomic Medicine The New York State Task Force on Life and the Law New York 347–86
C Bayley (2004) The challenge of physician education in genetics G Magill (Eds) Genetics and Ethics: An Interdisciplinary Study Saint Louis University Press Saint Louis 176–85
GEOQ. Goupe d’Etude en Oncologie du Quebec 2005. Ref Type: Internet Communication.
PW Yoon MT Scheuner MJ Khoury (2003) ArticleTitleResearch priorities for evaluating family history in the prevention of common chronic diseases Am J Prev Med 24 IssueID2 128–35 Occurrence Handle10.1016/S0749-3797(02)00585-8 Occurrence Handle12568818
A Antoniou PD Pharoah S Narod et al. (2003) ArticleTitleAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 72 IssueID5 1117–30 Occurrence Handle10.1086/375033 Occurrence Handle1:CAS:528:DC%2BD3sXjslagtbg%3D Occurrence Handle12677558
DE Goldgar DF Easton AM Deffenbaugh et al. (2004) ArticleTitleIntegrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2 Am J Hum Genet 75 IssueID4 535–44 Occurrence Handle10.1086/424388 Occurrence Handle1:CAS:528:DC%2BD2cXnvFaktLg%3D Occurrence Handle15290653
AC Antoniou DF Easton (2003) ArticleTitlePolygenic inheritance of breast cancer: Implications for design of association studies Genet Epidemiol 25 IssueID3 190–202 Occurrence Handle10.1002/gepi.10261 Occurrence Handle14557987
CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 2004; 74(6): 1175–82.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
* The Interdisciplinary Health Research International Team on Breast Cancer Susceptibility (INHERIT BRCAs) is an international team of researchers with a major interest in inherited breast cancer. The team is funded by the Canadian Institutes of Health Research. Other members and collaborators of INHERIT BRCAs involved in this study are listed in Appendix A.
Rights and permissions
About this article
Cite this article
Avard, D., Bridge, P., Bucci, L.M. et al. Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges. Familial Cancer 5, 3–13 (2006). https://doi.org/10.1007/s10689-005-2570-8
Issue Date:
DOI: https://doi.org/10.1007/s10689-005-2570-8